ERYTECH Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital –July 31st, 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers

LYON, France--()--Regulatory News:

ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY):

Listing market: Euronext Paris from Euronext
Market segment : segment C

ISIN Code : FR0011471135

website : www.erytech.com

Date  

Total of shares composing
the share capital

 

Total of brut(1) voting
rights

 

Total of net(2) voting
rights

January 1st, 2017   8 732 648   10 410 050   10 407 550
February 28, 2017   8 732 648   10 395 830   10 393 330
March 31, 2017   8 734 698   10 351 950   10 349 450
April 19, 2017   11 740 648(3)   13 303 800   13 301 300
April 30, 2017   11 743 148(4)   13 303 549   13 301 049
May 31, 2017   11 744 148(4)   13 304 550   13 302 050
June 30, 2017   11 744 448(4)   13 298 756   13 296 256
July 31,2017   11 744 448   13 300 266   13 297 766

(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares
(3) The number of shares and voting rights raised following the issuance of 3 000 000 new shares (cf. Note d’opération Visa n°17-161 available on the Company’s website)
(4) The number of shares increased due to issuance of shares consequently to warrants exercises which a Board of Director will take notice of in the future.

Contacts

ERYTECH Pharma

Contacts

ERYTECH Pharma